Paragon Global CRS
Paragon Global CRS is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects with Moderate-to-Severe Atopic Dermatitis
Sponsor Galderma S.A.
- Start (EU)
- Latest update
- Estimated end
A Phase 1/2 Randomized, Blinded, Dose-escalation Study to Evaluate the Safety and Efficacy of Intrathecal Administration of AAV9-ABCD1 Gene Therapy (SBT101) in Adult Patients with Adrenomyeloneuropathy
Sponsor Swanbio Therapeutics Limited
- Start (EU)
- Latest update
- Estimated end
A Phase 3, 52-week, open-label, single arm study to investigate the efficacy and safety of mepolizumab SC in participants aged 6 to 17 years with hypereosinophilic syndrome.
Sponsor Glaxosmithkline Research & Development Limited
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Paragon Global CRS?
The 2026-10-09 snapshot links Paragon Global CRS to 3 distinct CTIS trials. Recorded services include Patient Reimbursement and Travel, patients reimbursement, Patients' travel expenses reimbursement. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Paragon Global CRS?
The most frequently recorded therapeutic areas are Dermatology, Immunology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Paragon Global CRS conducted?
The linked trials record locations in 14 countries, including Netherlands, Spain, Austria, Belgium, Bulgaria. These are trial locations, not confirmed office locations or countries where Paragon Global CRS delivered services.
What can this page tell me about Paragon Global CRS's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Paragon Global CRS. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Paragon Global CRS B.V.